Evidence map›Paper›PMID 26659084›Full record

Observational studyInternational journal of clinical pharmacy2016

An evaluation of clinical pharmacist service on a neurology care unit.

Zhan-Miao Yi, Shu-Sen Sun, Xiao-Xiao Li, Ming Lu, Suo-Di Zhai

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of clinical pharmacy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Drug-related problems in hospitalised Parkinson's disease patients in China.European journal of hospital pharmacy : science and practice · 2022
    Article
  4. Article
  5. Article
  6. Ambulatory care pharmacy practice in China: status and future efforts.International journal of clinical pharmacy · 2020
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Zhan-Miao YiPeking University Third Hospital, Beijing, China.
Shu-Sen SunCollege of Pharmacy, Western New England University, Springfield, MA, USA.
Xiao-Xiao LiPeking University Third Hospital, Beijing, China.
Ming LuPeking University Third Hospital, Beijing, China.
Suo-Di ZhaiPeking University Third Hospital, Beijing, China. zhaisuodi@163.com.
Peking University · CNPeking University Third Hospital · CNWestern New England University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedications used to treat neurological diseases may result in adverse effects. Research is needed to demonstrate pharmacist value and their roles in patient care.

objectiveTo categorize the types and severities of the prescribing errors intercepted and to describe clinical activities conducted by neurology ward pharmacists.

methodPharmacists prospectively reviewed medication orders over an 18-month period with inventions documented and categorized.

resultsA total of 341 prescribing errors in 1183 patients were intercepted. The most common error types were dosing frequency (35.8 %) and medication selection (21.5 %). The top five most detected error medications were those indicated for hyperhomocysteinemia (22.0 %), stress ulcer prophylaxis (12.3 %), poor circulation (10.9 %), hyperglycemia (6.5 %), and infections (5.9 %). Although 67.5 % of the detected errors having the potential causing no harm, 26.4 % of the errors may require intervention, and 6.2 % may increase the length of stay. The number of errors decreased from 19 to 10 per month during the study period. Clinical pharmacists also actively engaged in medication use evaluation, clinical decision support system optimization, and education to patients and providers.

conclusionPresence of clinical pharmacists at the neurology unit may help in early detection of prescribing errors with increased patient safety.

Indexed as

Drug PrescriptionsHospital UnitsMedication Therapy ManagementNeurologyPharmacistsPharmacy Service, HospitalDrug Administration ScheduleDrug CompoundingDrug-Related Side Effects and Adverse ReactionsHumansInappropriate PrescribingMedication ReconciliationPatient SafetyProfessional RoleProgram EvaluationProspective StudiesChinaClinical pharmacistMedication reviewNeurologyPrescription errorsQuality improvement

Identifiers

PMID26659084
OpenAlexW2289534291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.